VKH
CALA

Virtu KCG Holdings’s Calithera Biosciences, Inc CALA Stock Holding History

Virtu KCG Holdings’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-623
Closed -$144K – 3665
2017
Q1 		$144K Buy
+623
New +$108K ﹤0.01% 2565
2016
Q4 		– Sell
-857
Closed -$56K – 3931
2016
Q3 		$56K Buy
+857
New +$55.2K ﹤0.01% 2765
2015
Q4 		– Sell
-1,103
Closed -$120K – 4064
2015
Q3 		$120K Buy
+1,103
New +$143K ﹤0.01% 2775

Other funds holding CALA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Virtu KCG Holdings's CALA Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Calithera Biosciences, Inc (CALA) in Q2 2017, closing a stake of 623 shares — an estimated $144K sold.

Virtu KCG Holdings first reported a position in CALA in Q3 2015 and held it in 3 quarters. The position peaked at $144K in Q1 2017. 94 funds tracked by Wall St. Rank hold CALA as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Calithera Biosciences, Inc position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 623 Calithera Biosciences, Inc shares in Q2 2017, an estimated $144K.
  • Virtu KCG Holdings first reported a position in Calithera Biosciences, Inc in Q3 2015 and held it in 3 quarters.
  • Virtu KCG Holdings's Calithera Biosciences, Inc position peaked at $144K in Q1 2017.
  • 94 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.